On October 20, 2023, Ildong Pharmaceutical Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,440 KRW | -1.40% | -0.77% | -14.98% |
2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.98% | 315M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- A249420 Stock
- News Ildong Pharmaceutical Co., Ltd.
- Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 30 billion in funding